NeilMed
international pharmaceutical company
NeilMed Pharmaceuticals Inc. is an American pharmaceutical, medical devices' manufacturer & supplier company based in Santa Rosa, California. It manufactures and supplies nasal saline over-the-counter products, including the patented Sinus Rinse Kit, a nasal irrigation system.
History
NeilMed Pharmaceuticals was founded by Ketan C. Mehta, a pulmonary and critical-care physician, and Nina Mehta in the year 2000. It started as a side project in 1999 to build a device that could be used to effectively and naturally rinse the sinuses for sinusitis sufferers known as NeilMed Sinus Rinse. In early 2005, the company developed the NasaFlo Neti Pot for nasal irrigation. The products were initially sold regionally and later expanded services nationwide in the U.S. and then to several countries in Europe, North and South America, Asia and Oceania.
In May 2018 founders Ketan Mehta and Nina Mehta established the NeilMed Endowed Support Fund in the Department of Otolaryngology at the Wayne State University School of Medicine in Detroit.
In November 2021, the company expanded its production facility in Sonoma County. It has additional facilities in Southern California, New Jersey, Japan, Canada, etc.
Begin with the source’s own compact description: “NeilMed” is international pharmaceutical company. The dossier treats that line as a proposition to test through NeilMed, international and pharmaceutical, not as a finished interpretation.
Why this record matters
The phrase “international pharmaceutical company” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Contemporary correspondence, administrative files and participant testimony can test how later narratives organized the event or institution. The source revision retrieved here is dated Sep 10, 2026. The linked authority identifier is Q85644511. 1 of 7 selected statements include explicit references; 7 carry qualifiers and 0 use preferred rank. The first chronological checks are 2000, 1999, 2005 and 2018.
Later summaries often reconcile disputed chronology or motive more neatly than the contemporary record permits. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Compare institutional narratives with records created by participants and affected communities. Dates and formal titles are useful anchors, but not substitutes for context.
- Event chronology
- Institutional context
- Locating named record creators
Contemporary correspondence, government or organizational records, oral histories and cited historical scholarship.
Three-step research path
- Establish the record: confirm the title “NeilMed”, its source revision and the description used here.
- Expand the search: follow NeilMed primary sources, NeilMed archive and NeilMed research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “NeilMed”?
- Which voices are present, absent or mediated by the institution?
- Who created the surviving record, and for what administrative purpose?
Search terms from this dossier
This entry incorporates text from “NeilMed” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.